NCT06393127View on ClinicalTrials.gov

A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

September 10, 2024

Study Completion Date

September 10, 2024

Conditions
Healthy
Interventions
DRUG

BI 1015550 Formulation C2

BI 1015550 Formulation C2

DRUG

BI 1015550 Formulation C1

BI 1015550 Formulation C1

Trial Locations (1)

10117

Charité Research Organisation GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06393127 - A Study in Healthy People to Compare How 2 Different High Dose Formulations of BI 1015550 Are Taken up in the Body | Biotech Hunter | Biotech Hunter